Cystic Foundation released the following clinical trial alert in February.
February 18, 2022
Study of Lefamulin in Adults with CF
Status: Enrolling
Description: This study will look at the safety and how the body processes lefamulin, a drug intended to treat infections in the lung. This study is for adults with CF.
Age: 18 Years and Older
Mutation: No Mutation Requirement
Fev1% Predicted: 40% or greater
Number of Visits: 6
Length of Participation: 13 days
ClinicalTrials.gov link: https://clinicaltrials.gov/ct2/show/NCT05225805